HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
22:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
management of heart failure with reduced :@0.076190:0.099847:0.775026:0.099847:0.775026:0.063183:0.076190:0.063183:0.030238:0.022175:0.020159:0.022175:0.022175:0.021503:0.031582:0.021503:0.020159:0.010079:0.009407:0.021503:0.009407:0.009407:0.020159:0.021503:0.022175:0.010751:0.010079:0.009407:0.009407:0.022175:0.008063:0.008063:0.020159:0.010751:0.021503:0.009407:0.026878:0.008063:0.010079:0.020159:0.009407:0.010751:0.021503:0.022175:0.020159:0.021503:0.021503:0.022175:0.009407
ejection fraction (Hfref):@0.076190:0.128069:0.460550:0.128069:0.460550:0.091406:0.076190:0.091406:0.021503:0.008735:0.021503:0.021503:0.010079:0.008063:0.021503:0.020159:0.009407:0.009407:0.010751:0.022175:0.021503:0.010079:0.008063:0.021503:0.020159:0.009407:0.012767:0.022847:0.016127:0.010751:0.017471:0.016127:0.012767
mC Hendrickse:@0.076190:0.169924:0.200502:0.169924:0.200502:0.151592:0.076190:0.151592:0.015119:0.013103:0.004704:0.011423:0.010751:0.010079:0.011087:0.005376:0.004032:0.010751:0.009743:0.007392:0.010751
MBChB (UCT), FCp (sA), Cert. Cardio:@0.076190:0.181888:0.313311:0.181888:0.313311:0.167859:0.076190:0.167859:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.004959:0.008803:0.010926:0.005725:0.004959:0.003723:0.003723:0.006518:0.010926:0.007956:0.003723:0.004959:0.006693:0.009945:0.004959:0.003723:0.003723:0.010926:0.008735:0.004045:0.004556:0.003723:0.003723:0.010926:0.009179:0.004045:0.009206:0.002688:0.008803
Specialist Cardiologist in Private Practice, Cape Town:@0.076190:0.199776:0.422329:0.199776:0.422329:0.185747:0.076190:0.185747:0.006693:0.009165:0.008735:0.008695:0.002688:0.009179:0.002688:0.002688:0.005214:0.004556:0.003723:0.010926:0.009179:0.004045:0.009206:0.002688:0.008803:0.002688:0.008803:0.009045:0.002688:0.005214:0.004556:0.003723:0.002688:0.008198:0.003723:0.007956:0.004045:0.002688:0.007445:0.009179:0.004556:0.008735:0.003723:0.007956:0.004045:0.009179:0.008695:0.004556:0.002688:0.008695:0.008735:0.003723:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198
Heart  failure is a clinical syndrome  characterised  by :@0.076190:0.229593:0.485115:0.229593:0.485115:0.213811:0.076190:0.213811:0.010326:0.009827:0.010326:0.004551:0.005125:0.004188:0.003870:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.008074:0.003024:0.005866:0.008074:0.010326:0.008074:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.008074:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004188:0.003870:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.009827:0.010357:0.004188:0.003870:0.010311:0.008104:0.004188
typical  symptoms (e.g. breathlessness, ankle-swelling :@0.076190:0.243633:0.485130:0.243633:0.485130:0.227850:0.076190:0.227850:0.005125:0.008104:0.010311:0.003024:0.009782:0.010326:0.003024:0.004188:0.005050:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.009223:0.005579:0.009827:0.004188:0.010175:0.004188:0.009223:0.010311:0.004551:0.009827:0.010326:0.005125:0.009223:0.003024:0.009827:0.005866:0.005866:0.009223:0.009827:0.005866:0.005866:0.004188:0.009223:0.010326:0.009223:0.007590:0.003024:0.009827:0.005020:0.005866:0.012564:0.009827:0.003024:0.003024:0.003024:0.009223:0.010175:0.004188
and fatigue) that may be accompanied by signs (e.g., :@0.076190:0.257672:0.485115:0.257672:0.485115:0.241889:0.076190:0.241889:0.010326:0.009223:0.010357:0.004566:0.004747:0.010326:0.005125:0.003024:0.010175:0.009192:0.009827:0.005579:0.004566:0.005125:0.009223:0.010326:0.005125:0.004566:0.014182:0.010326:0.008104:0.004566:0.010311:0.009827:0.004566:0.010326:0.009782:0.009782:0.009903:0.014182:0.010311:0.010326:0.009223:0.003024:0.009827:0.010357:0.004566:0.010311:0.008104:0.004566:0.005866:0.003024:0.010175:0.009223:0.005866:0.004566:0.005579:0.009827:0.004188:0.010175:0.004188:0.004188:0.004188
elevated jugular venous pressure,  pulmonary crackles :@0.076190:0.271711:0.485145:0.271711:0.485145:0.255929:0.076190:0.255929:0.009827:0.003024:0.009827:0.008376:0.010326:0.005125:0.009827:0.010357:0.006486:0.003069:0.009192:0.010175:0.009192:0.003024:0.010326:0.004551:0.006486:0.008376:0.009827:0.009223:0.009903:0.009192:0.005866:0.006486:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188:0.004188:0.002283:0.010311:0.009192:0.003024:0.014182:0.009903:0.009223:0.010326:0.004551:0.008104:0.006486:0.009782:0.004551:0.010326:0.009782:0.007590:0.003024:0.009827:0.005866:0.004188
and peripheral oedema) caused by a structural and/or :@0.076190:0.285750:0.485130:0.285750:0.485130:0.269968:0.076190:0.269968:0.010326:0.009223:0.010357:0.004007:0.010311:0.009827:0.004551:0.003024:0.010311:0.009223:0.009827:0.004551:0.010326:0.003024:0.004007:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.005579:0.004007:0.009782:0.010326:0.009192:0.005866:0.009827:0.010357:0.004022:0.010311:0.008104:0.004022:0.010326:0.004007:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.009192:0.004551:0.010326:0.003024:0.004007:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.004188
functional cardiac abnormality, resulting in a reduced :@0.076190:0.299790:0.485145:0.299790:0.485145:0.284007:0.076190:0.284007:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.005715:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.005715:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.005715:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.003024:0.009223:0.010175:0.005715:0.003024:0.009223:0.005715:0.010326:0.005715:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.004188
cardiac output and/or elevated intracardiac pressures :@0.076190:0.313829:0.485145:0.313829:0.485145:0.298046:0.076190:0.298046:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.004778:0.009903:0.009192:0.005125:0.010311:0.009192:0.005110:0.004778:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.004762:0.009827:0.003024:0.009827:0.008376:0.010326:0.005125:0.009827:0.010357:0.004778:0.003024:0.009223:0.005125:0.004551:0.010326:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.004778:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.005866:0.004188
at rest or during stress.:@0.076190:0.327868:0.236029:0.327868:0.236029:0.312086:0.076190:0.312086:0.010326:0.005125:0.004188:0.004551:0.009827:0.005866:0.005125:0.004188:0.009903:0.004551:0.004188:0.010357:0.009192:0.004551:0.003024:0.009223:0.010175:0.004188:0.005866:0.005125:0.004551:0.009827:0.005866:0.005866:0.004188
The clinical syndrome is characterised by progressive :@0.090478:0.341908:0.485145:0.341908:0.485145:0.326125:0.090478:0.326125:0.006441:0.009223:0.009827:0.004929:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004944:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004929:0.003024:0.005866:0.004944:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.009827:0.010357:0.004929:0.010311:0.008104:0.004944:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.008376:0.009827:0.004188
fluid overload, resulting from the maladaptations to car:@0.076190:0.355947:0.475923:0.355947:0.475923:0.340164:0.076190:0.340164:0.003666:0.003666:0.009192:0.003024:0.010357:0.003523:0.009903:0.008376:0.009827:0.004551:0.003024:0.009903:0.010326:0.010357:0.004188:0.003523:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.003024:0.009223:0.010175:0.003523:0.004747:0.004551:0.009903:0.014182:0.003523:0.005125:0.009223:0.009827:0.003523:0.014182:0.010326:0.003024:0.010326:0.010357:0.010326:0.010311:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.003538:0.005125:0.009903:0.003523:0.009782:0.010326:0.004551
-:@0.475923:0.355947:0.480942:0.355947:0.480942:0.340164:0.475923:0.340164:0.005020
diac dysfunction stemming from a multitude of causes, :@0.076190:0.369986:0.485160:0.369986:0.485160:0.354203:0.076190:0.354203:0.010357:0.003024:0.010326:0.009782:0.004672:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004657:0.005866:0.005125:0.009827:0.014182:0.014182:0.003024:0.009223:0.010175:0.004672:0.004747:0.004551:0.009903:0.014182:0.004672:0.010326:0.004672:0.014182:0.009192:0.003024:0.005125:0.003024:0.005125:0.009192:0.010357:0.009827:0.004672:0.009903:0.004747:0.004672:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.004188:0.004188
including hypertension,  ischaemia, valvular heart  dis-:@0.076190:0.384025:0.480942:0.384025:0.480942:0.368243:0.076190:0.368243:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.007817:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188:0.003613:0.003024:0.005866:0.009782:0.009223:0.010326:0.009827:0.014182:0.003024:0.010326:0.004188:0.007817:0.008376:0.010326:0.003024:0.008376:0.009192:0.003024:0.010326:0.004551:0.007817:0.009223:0.009827:0.010326:0.004551:0.005125:0.004188:0.003613:0.010357:0.003024:0.005866:0.005020
ease, intrinsic muscle disease and pericardial disease. :@0.076190:0.398065:0.485130:0.398065:0.485130:0.382282:0.076190:0.382282:0.009827:0.010326:0.005866:0.009827:0.004188:0.006093:0.003024:0.009223:0.005125:0.004551:0.003024:0.009223:0.005866:0.003024:0.009782:0.006108:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.006108:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.006108:0.010326:0.009223:0.010357:0.006093:0.010311:0.009827:0.004551:0.003024:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.003024:0.006108:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004188
Heart  failure  includes a  broad  spectrum  of  patients :@0.076190:0.412104:0.485115:0.412104:0.485115:0.396321:0.076190:0.396321:0.010326:0.009827:0.010326:0.004551:0.005125:0.004188:0.004596:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.004596:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005866:0.008799:0.010326:0.004188:0.004596:0.010311:0.004551:0.009903:0.010326:0.010357:0.004188:0.004596:0.005866:0.010311:0.009827:0.009782:0.005125:0.004551:0.009192:0.014182:0.004188:0.004596:0.009903:0.004747:0.004188:0.004596:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
–  from  those  with  normal  left  ventricular  systolic func-:@0.076190:0.426143:0.480927:0.426143:0.480927:0.410361:0.076190:0.410361:0.007560:0.004188:0.002600:0.004747:0.004551:0.009903:0.014182:0.004188:0.002600:0.005125:0.009223:0.009903:0.005866:0.009827:0.004188:0.002600:0.012564:0.003024:0.005125:0.009223:0.004188:0.002600:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.004188:0.002600:0.003024:0.009827:0.004747:0.005125:0.004188:0.002600:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.002600:0.005866:0.008104:0.005866:0.005125:0.009903:0.003024:0.003024:0.009782:0.006804:0.004747:0.009192:0.009223:0.009782:0.005020
tion (EF >50%) to those with mid-range ejection fraction :@0.076190:0.440182:0.485145:0.440182:0.485145:0.424400:0.076190:0.424400:0.005125:0.003024:0.009903:0.009223:0.004400:0.005579:0.008104:0.007333:0.004400:0.009162:0.008376:0.008376:0.011717:0.005579:0.004415:0.005125:0.009903:0.004400:0.005125:0.009223:0.009903:0.005866:0.009827:0.004400:0.012564:0.003024:0.005125:0.009223:0.004400:0.014182:0.003024:0.010357:0.005020:0.004551:0.010326:0.009223:0.010175:0.009827:0.004400:0.009827:0.003069:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004400:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
(EF 40-49%) and reduced left ventricular ejection frac-:@0.076190:0.454222:0.480957:0.454222:0.480957:0.438439:0.076190:0.438439:0.005579:0.008104:0.007333:0.005745:0.008376:0.008376:0.005020:0.008391:0.008376:0.011717:0.005579:0.005745:0.010326:0.009223:0.010357:0.005745:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.005730:0.003024:0.009827:0.004747:0.005125:0.005745:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.005745:0.009827:0.003069:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.005730:0.004747:0.004551:0.010326:0.009782:0.005020
tion (EF ≤40%). This article focuses mainly on the man:@0.076190:0.468261:0.475923:0.468261:0.475923:0.452478:0.076190:0.452478:0.005125:0.003024:0.009903:0.009223:0.006063:0.005579:0.008104:0.007333:0.006078:0.008300:0.008376:0.008376:0.011717:0.005579:0.004188:0.006063:0.006441:0.009223:0.003024:0.005866:0.006063:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.006063:0.004747:0.009903:0.009782:0.009192:0.005866:0.009827:0.005866:0.006063:0.014182:0.010326:0.003024:0.009223:0.003024:0.008104:0.006078:0.009903:0.009223:0.006063:0.005125:0.009223:0.009827:0.006063:0.014182:0.010326:0.009223
-:@0.475923:0.468261:0.480942:0.468261:0.480942:0.452478:0.475923:0.452478:0.005020
agement of patients with heart failure and reduced left :@0.076190:0.482300:0.485145:0.482300:0.485145:0.466518:0.076190:0.466518:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004037:0.009903:0.004747:0.004052:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004052:0.012564:0.003024:0.005125:0.009223:0.004052:0.009223:0.009827:0.010326:0.004551:0.005125:0.004052:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004052:0.010326:0.009223:0.010357:0.004052:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.004052:0.003024:0.009827:0.004747:0.005125:0.004188
ventricular ejection fraction, HF:@0.076190:0.496339:0.304065:0.496339:0.304065:0.480557:0.076190:0.480557:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.009827:0.003069:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.010326:0.007333
r:@0.304034:0.496339:0.308585:0.496339:0.308585:0.480557:0.304034:0.480557:0.004551
EF (EF ≤40%).:@0.308585:0.496339:0.399949:0.496339:0.399949:0.480557:0.308585:0.480557:0.008104:0.007333:0.004188:0.005579:0.008104:0.007333:0.004188:0.008300:0.008376:0.008376:0.011717:0.005579:0.004188
In modern practice, the ejection fraction is  usually :@0.090478:0.510379:0.485145:0.510379:0.485145:0.494596:0.090478:0.494596:0.003417:0.009223:0.007801:0.014182:0.009903:0.010357:0.009827:0.004551:0.009223:0.007801:0.010311:0.004551:0.010326:0.009782:0.005125:0.003024:0.009782:0.009827:0.004188:0.007801:0.005125:0.009223:0.009827:0.007801:0.009827:0.003069:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.007801:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.007801:0.003024:0.005866:0.004188:0.003629:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.004188
assessed  using echocardiography.  However,  radionu-:@0.076190:0.524418:0.480957:0.524418:0.480957:0.508635:0.076190:0.508635:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.009827:0.010357:0.004188:0.003024:0.009192:0.005866:0.003024:0.009223:0.010175:0.007197:0.009827:0.009782:0.009223:0.009903:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.010175:0.004551:0.010326:0.010311:0.009223:0.008104:0.004188:0.004188:0.002994:0.010326:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188:0.002994:0.004551:0.010326:0.010357:0.003024:0.009903:0.009223:0.009192:0.005020
cleotide techniques, cardiac magnetic resonance im-:@0.076190:0.538457:0.480927:0.538457:0.480927:0.522675:0.076190:0.522675:0.009782:0.003024:0.009827:0.009903:0.005125:0.003024:0.010357:0.009827:0.005549:0.005125:0.009827:0.009782:0.009223:0.009207:0.003024:0.010311:0.009192:0.009827:0.005866:0.004188:0.005549:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.005549:0.014182:0.010326:0.010175:0.009223:0.009827:0.005125:0.003024:0.009782:0.005549:0.004551:0.009827:0.005866:0.009903:0.009223:0.010326:0.009223:0.009782:0.009827:0.005534:0.003024:0.014182:0.005020
aging (CMR) and CT-scanning may also be used, with :@0.076190:0.552497:0.485130:0.552497:0.485130:0.536714:0.076190:0.536714:0.010326:0.010175:0.003024:0.009223:0.010175:0.005443:0.005579:0.012292:0.013894:0.009177:0.005579:0.005443:0.010326:0.009223:0.010357:0.005443:0.012292:0.006441:0.005020:0.005866:0.009782:0.010326:0.009223:0.009223:0.003024:0.009223:0.010175:0.005443:0.014182:0.010326:0.008104:0.005458:0.010326:0.003024:0.005866:0.009903:0.005458:0.010311:0.009827:0.005443:0.009192:0.005866:0.009827:0.010357:0.004188:0.005443:0.012564:0.003024:0.005125:0.009223:0.004188
the added advantage of picking up various aetiologi-:@0.076190:0.566536:0.480957:0.566536:0.480957:0.550753:0.076190:0.550753:0.005125:0.009223:0.009827:0.005337:0.010326:0.010357:0.010357:0.009827:0.010357:0.005352:0.010326:0.010357:0.008376:0.010326:0.009223:0.005125:0.010326:0.010175:0.009827:0.005352:0.009903:0.004747:0.005337:0.010311:0.003024:0.009782:0.007590:0.003024:0.009223:0.010175:0.005352:0.009192:0.010311:0.005352:0.008376:0.010326:0.004551:0.003024:0.009903:0.009192:0.005866:0.005352:0.010326:0.009827:0.005125:0.003024:0.009903:0.003024:0.009903:0.010175:0.003024:0.005020
cal factors resulting in cardiac dysfunction. Cardiac MR :@0.076190:0.580575:0.485145:0.580575:0.485145:0.564792:0.076190:0.564792:0.009782:0.010326:0.003024:0.004067:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004067:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.003024:0.009223:0.010175:0.004067:0.003024:0.009223:0.004067:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.004067:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004067:0.012292:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.004067:0.013894:0.009177:0.004188
is effective in delineating pathology that may otherwise :@0.076190:0.594614:0.485145:0.594614:0.485145:0.578832:0.076190:0.578832:0.003024:0.005866:0.003825:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.003825:0.003024:0.009223:0.003825:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.010326:0.005125:0.003024:0.009223:0.010175:0.003825:0.010311:0.010326:0.005125:0.009223:0.009903:0.003024:0.009903:0.010175:0.008104:0.003825:0.005125:0.009223:0.010326:0.005125:0.003825:0.014182:0.010326:0.008104:0.003825:0.009903:0.005125:0.009223:0.009827:0.004551:0.012564:0.003024:0.005866:0.009827:0.004188
be missed using conventional echocardiographic tech-:@0.076190:0.608654:0.480942:0.608654:0.480942:0.592871:0.076190:0.592871:0.010311:0.009827:0.003598:0.014182:0.003024:0.005866:0.005866:0.009827:0.010357:0.003613:0.009192:0.005866:0.003024:0.009223:0.010175:0.003598:0.009782:0.009903:0.009223:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003598:0.009827:0.009782:0.009223:0.009903:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.010175:0.004551:0.010326:0.010311:0.009223:0.003024:0.009782:0.003598:0.005125:0.009827:0.009782:0.009223:0.005020
niques,  such  as  infiltrative  conditions,  i.e.  sarcoidosis. :@0.076190:0.622693:0.485115:0.622693:0.485115:0.606910:0.076190:0.606910:0.009223:0.003024:0.010311:0.009192:0.009827:0.005866:0.004188:0.004188:0.004203:0.005866:0.009192:0.009782:0.009223:0.004188:0.004203:0.010326:0.005866:0.004188:0.004218:0.003024:0.009223:0.003681:0.003681:0.003024:0.005125:0.004551:0.010326:0.005125:0.003024:0.008376:0.009827:0.004188:0.004203:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004188:0.004203:0.003024:0.004188:0.009827:0.004188:0.004188:0.004203:0.005866:0.010326:0.004551:0.009782:0.009903:0.003024:0.010357:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188
Functional MRI has become increasingly popular as a :@0.076190:0.636732:0.485130:0.636732:0.485130:0.620949:0.076190:0.620949:0.007333:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.006078:0.013894:0.009177:0.003417:0.006078:0.009223:0.010326:0.005866:0.006078:0.010311:0.009827:0.009782:0.009903:0.014182:0.009827:0.006078:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.003024:0.008104:0.006093:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.004551:0.006078:0.010326:0.005866:0.006093:0.010326:0.004188
non-invasive method for assessing myocardial viability :@0.076190:0.650771:0.485130:0.650771:0.485130:0.634989:0.076190:0.634989:0.009223:0.009903:0.009223:0.005020:0.003024:0.009223:0.008376:0.010326:0.005866:0.003024:0.008376:0.009827:0.006320:0.014182:0.009827:0.005125:0.009223:0.009903:0.010357:0.006305:0.004747:0.009903:0.004551:0.006305:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.003024:0.009223:0.010175:0.006320:0.014182:0.008104:0.009903:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.003024:0.006320:0.008376:0.003024:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188
and perfusion.:@0.076190:0.664811:0.181116:0.664811:0.181116:0.649028:0.076190:0.649028:0.010326:0.009223:0.010357:0.004188:0.010311:0.009827:0.004551:0.004747:0.009192:0.005866:0.003024:0.009903:0.009223:0.004188
patients with heart failure are often very complex to di-:@0.090478:0.678850:0.480942:0.678850:0.480942:0.663067:0.090478:0.663067:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003024:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.009827:0.010326:0.004551:0.005125:0.003024:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.003024:0.010326:0.004551:0.009827:0.003024:0.009903:0.004747:0.005125:0.009827:0.009223:0.003024:0.008376:0.009827:0.004551:0.008104:0.003024:0.009782:0.009903:0.014182:0.010311:0.003024:0.009827:0.007257:0.003024:0.005125:0.009903:0.003024:0.010357:0.003024:0.005020
agnose as they often have a range of other comorbidi-:@0.076190:0.692889:0.480957:0.692889:0.480957:0.677107:0.076190:0.677107:0.010326:0.010175:0.009223:0.009903:0.005866:0.009827:0.004067:0.010326:0.005866:0.004082:0.005125:0.009223:0.009827:0.008104:0.004067:0.009903:0.004747:0.005125:0.009827:0.009223:0.004067:0.009223:0.010326:0.008376:0.009827:0.004067:0.010326:0.004082:0.004551:0.010326:0.009223:0.010175:0.009827:0.004067:0.009903:0.004747:0.004067:0.009903:0.005125:0.009223:0.009827:0.004551:0.004067:0.009782:0.009903:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005020
ties,  including  hypertension,  diabetes mellitus, cancer :@0.076190:0.706928:0.485145:0.706928:0.485145:0.691146:0.076190:0.691146:0.005125:0.003024:0.009827:0.005866:0.004188:0.004188:0.002948:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.004188:0.002948:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188:0.002948:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.009827:0.005866:0.007151:0.014182:0.009827:0.003024:0.003024:0.003024:0.005125:0.009192:0.005866:0.004188:0.007151:0.009782:0.010326:0.009223:0.009782:0.009827:0.004551:0.004188
and other general medical conditions. Initial investiga-:@0.076190:0.720968:0.480942:0.720968:0.480942:0.705185:0.076190:0.705185:0.010326:0.009223:0.010357:0.005337:0.009903:0.005125:0.009207:0.009827:0.004551:0.005322:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.005337:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.003024:0.005337:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.005322:0.003417:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.005337:0.003024:0.009223:0.008376:0.009827:0.005866:0.005125:0.003024:0.010175:0.010326:0.005020
tion and treatment of heart failure with reduced ejec-:@0.076190:0.735007:0.480927:0.735007:0.480927:0.719224:0.076190:0.719224:0.005125:0.003024:0.009903:0.009223:0.005564:0.010326:0.009223:0.010357:0.005564:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005549:0.009903:0.004747:0.005564:0.009223:0.009827:0.010326:0.004551:0.005125:0.005564:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005564:0.012564:0.003024:0.005125:0.009223:0.005564:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.005564:0.009827:0.003069:0.009827:0.009782:0.005020
tion fraction differs according to the duration of symp-:@0.076190:0.749046:0.480927:0.749046:0.480927:0.733264:0.076190:0.733264:0.005125:0.003024:0.009903:0.009223:0.005186:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.005186:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.005866:0.005201:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.005186:0.005125:0.009903:0.005186:0.005125:0.009223:0.009827:0.005186:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.005186:0.009903:0.004747:0.005186:0.005866:0.008104:0.014182:0.010311:0.005020
toms and whether the heart failure is of new onset (:@0.076190:0.763085:0.460758:0.763085:0.460758:0.747303:0.076190:0.747303:0.005125:0.009903:0.014182:0.005866:0.005065:0.010326:0.009223:0.010357:0.005065:0.012564:0.009223:0.009827:0.005125:0.009223:0.009827:0.004551:0.005050:0.005125:0.009223:0.009827:0.005065:0.009223:0.009827:0.010326:0.004551:0.005125:0.005065:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005065:0.003024:0.005866:0.005080:0.009903:0.004747:0.005065:0.009223:0.009827:0.012564:0.005065:0.009903:0.009223:0.005866:0.009827:0.005125:0.005065:0.005579
de :@0.460758:0.763085:0.485130:0.763085:0.485130:0.747303:0.460758:0.747303:0.010357:0.009827:0.004188
novo:@0.076190:0.777125:0.113595:0.777125:0.113595:0.761342:0.076190:0.761342:0.009223:0.009903:0.008376:0.009903
) or chronic. :@0.113595:0.777125:0.208482:0.777125:0.208482:0.761342:0.113595:0.761342:0.005579:0.005503:0.009903:0.004551:0.005488:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004188:0.004188
De novo:@0.209782:0.777125:0.273766:0.777125:0.273766:0.761342:0.209782:0.761342:0.011249:0.009827:0.005503:0.009223:0.009903:0.008376:0.009903
 heart failure may emanate :@0.273766:0.777125:0.485160:0.777125:0.485160:0.761342:0.273766:0.761342:0.005503:0.009223:0.009827:0.010326:0.004551:0.005125:0.005503:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005503:0.014182:0.010326:0.008104:0.005503:0.009827:0.014182:0.010326:0.009223:0.010326:0.005125:0.009827:0.004188
from an acute condition, such as an acute ischaemic :@0.076190:0.791164:0.485130:0.791164:0.485130:0.775381:0.076190:0.775381:0.004747:0.004551:0.009903:0.014182:0.005579:0.010326:0.009223:0.005594:0.010326:0.009782:0.009192:0.005125:0.009827:0.005594:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.005579:0.005866:0.009192:0.009782:0.009223:0.005594:0.010326:0.005866:0.005594:0.010326:0.009223:0.005594:0.010326:0.009782:0.009192:0.005125:0.009827:0.005594:0.003024:0.005866:0.009782:0.009223:0.010326:0.009827:0.014182:0.003024:0.009782:0.004188
event or myocarditis, or acutely decompensated di-:@0.076190:0.805203:0.480957:0.805203:0.480957:0.789421:0.076190:0.789421:0.009827:0.008376:0.009827:0.009223:0.005125:0.007726:0.009903:0.004551:0.007726:0.014182:0.008104:0.009903:0.009782:0.010326:0.004551:0.010357:0.003024:0.005125:0.003024:0.005866:0.004188:0.007726:0.009903:0.004551:0.007726:0.010326:0.009782:0.009192:0.005125:0.009827:0.003024:0.008104:0.007726:0.010357:0.009827:0.009782:0.009903:0.014182:0.010311:0.009827:0.009223:0.005866:0.010326:0.005125:0.009827:0.010357:0.007726:0.010357:0.003024:0.005020
lated cardiomyopathy that has developed over weeks :@0.076190:0.819243:0.485145:0.819243:0.485145:0.803460:0.076190:0.803460:0.003024:0.010326:0.005125:0.009827:0.010357:0.004596:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.014182:0.008104:0.009903:0.010311:0.010326:0.005125:0.009223:0.008104:0.004581:0.005125:0.009223:0.010326:0.005125:0.004581:0.009223:0.010326:0.005866:0.004596:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.009827:0.010357:0.004596:0.009903:0.008376:0.009827:0.004551:0.004581:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188
to years, becoming evident once a precipitating factor :@0.076190:0.833282:0.485160:0.833282:0.485160:0.817499:0.076190:0.817499:0.005125:0.009903:0.003901:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.003916:0.010311:0.009827:0.009782:0.009903:0.014182:0.003024:0.009223:0.010175:0.003916:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.005125:0.003916:0.009903:0.009223:0.009782:0.009827:0.003901:0.010326:0.003916:0.010311:0.004551:0.009827:0.009782:0.003024:0.010311:0.003024:0.005125:0.010326:0.005125:0.003024:0.009223:0.010175:0.003916:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.004188
“tips” the balance. :@0.076190:0.847321:0.219171:0.847321:0.219171:0.831538:0.076190:0.831538:0.007590:0.005125:0.003024:0.010311:0.005866:0.007318:0.004188:0.005125:0.009223:0.009827:0.004188:0.010311:0.010326:0.003024:0.010326:0.009223:0.009782:0.009827:0.004188:0.004188
Heart failure may be completely reversible, i.e. in the :@0.090478:0.861360:0.485115:0.861360:0.485115:0.845578:0.090478:0.845578:0.010326:0.009827:0.010326:0.004551:0.005125:0.004838:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004838:0.014182:0.010326:0.008104:0.004853:0.010311:0.009827:0.004838:0.009782:0.009903:0.014182:0.010311:0.003024:0.009827:0.005125:0.009827:0.003024:0.008104:0.004838:0.004551:0.009827:0.008376:0.009827:0.004551:0.005866:0.003024:0.010311:0.003024:0.009827:0.004188:0.004838:0.003024:0.004188:0.009827:0.004188:0.004838:0.003024:0.009223:0.004838:0.005125:0.009223:0.009827:0.004188
setting of acute viral myocarditis, tachycardia-induced :@0.076190:0.875400:0.485145:0.875400:0.485145:0.859617:0.076190:0.859617:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.004400:0.009903:0.004747:0.004415:0.010326:0.009782:0.009192:0.005125:0.009827:0.004415:0.008376:0.003024:0.004551:0.010326:0.003024:0.004415:0.014182:0.008104:0.009903:0.009782:0.010326:0.004551:0.010357:0.003024:0.005125:0.003024:0.005866:0.004188:0.004415:0.005125:0.010326:0.009782:0.009223:0.008104:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.005020:0.003024:0.009223:0.010357:0.009192:0.009782:0.009827:0.010357:0.004188
cardiomyopathy  or :@0.076190:0.889439:0.225551:0.889439:0.225551:0.873656:0.076190:0.873656:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.014182:0.008104:0.009903:0.010311:0.010326:0.005125:0.009223:0.008104:0.004188:0.003311:0.009903:0.004551:0.004188
Takotsubo:@0.228862:0.889439:0.303520:0.889439:0.303520:0.873656:0.228862:0.873656:0.006441:0.010326:0.007590:0.009903:0.005125:0.005866:0.009192:0.010311:0.009903
  (stress-induced cardio-:@0.303505:0.889439:0.480942:0.889439:0.480942:0.873656:0.303505:0.873656:0.004188:0.003311:0.005579:0.005866:0.005125:0.004551:0.009827:0.005866:0.005866:0.005020:0.003024:0.009223:0.010357:0.009192:0.009782:0.009827:0.010357:0.007514:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.005020
myopathy), and therefore  it is of utmost  importance :@0.076175:0.903478:0.485130:0.903478:0.485130:0.887696:0.076175:0.887696:0.014182:0.008104:0.009903:0.010311:0.010326:0.005125:0.009223:0.008104:0.005579:0.004188:0.007847:0.010326:0.009223:0.010357:0.007847:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.004188:0.003644:0.003024:0.005125:0.007847:0.003024:0.005866:0.007847:0.009903:0.004747:0.007847:0.009192:0.005125:0.014182:0.009903:0.005866:0.005125:0.004188:0.003644:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.009782:0.009827:0.004188
to define the aetiological mechanism which may then :@0.076175:0.917517:0.485130:0.917517:0.485130:0.901735:0.076175:0.901735:0.005125:0.009903:0.005140:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.005140:0.005125:0.009223:0.009827:0.005140:0.010326:0.009827:0.005125:0.003024:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.005156:0.014182:0.009827:0.009782:0.009223:0.010326:0.009223:0.003024:0.005866:0.014182:0.005156:0.012564:0.009223:0.003024:0.009782:0.009223:0.005156:0.014182:0.010326:0.008104:0.005156:0.005125:0.009223:0.009827:0.009223:0.004188
have a bearing on initial therapy, maintenance treat-:@0.076175:0.931557:0.480942:0.931557:0.480942:0.915774:0.076175:0.915774:0.009223:0.010326:0.008376:0.009827:0.005957:0.010326:0.005942:0.010311:0.009827:0.010326:0.004551:0.003024:0.009223:0.010175:0.005942:0.009903:0.009223:0.005942:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.005957:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.005942:0.014182:0.010326:0.003024:0.009223:0.005125:0.009827:0.009223:0.010326:0.009223:0.009782:0.009827:0.005942:0.005125:0.004551:0.009827:0.010326:0.005140:0.005020
ment and prognosis. :@0.076175:0.945596:0.230011:0.945596:0.230011:0.929813:0.076175:0.929813:0.014182:0.009827:0.009223:0.005125:0.004188:0.010326:0.009223:0.010357:0.004188:0.010311:0.004551:0.009903:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188
stable heart failure describes a patient with symptoms :@0.533314:0.168807:0.927967:0.168807:0.927967:0.153024:0.533314:0.153024:0.007529:0.005125:0.010326:0.010311:0.003024:0.009827:0.003492:0.009223:0.009827:0.010326:0.004551:0.005125:0.003477:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.003477:0.010357:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.005866:0.003492:0.010326:0.003492:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.003477:0.012564:0.003024:0.005125:0.009223:0.003492:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188
remaining unchanged for at least one month. Decom-:@0.519027:0.183469:0.923794:0.183469:0.923794:0.167687:0.519027:0.167687:0.004551:0.009827:0.014182:0.010326:0.003024:0.009223:0.003024:0.009223:0.010175:0.004899:0.009192:0.009223:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.010357:0.004899:0.004747:0.009903:0.004551:0.004899:0.010326:0.005125:0.004899:0.003024:0.009827:0.010326:0.005866:0.005125:0.004914:0.009903:0.009223:0.009827:0.004899:0.014182:0.009903:0.009223:0.005125:0.009223:0.004188:0.004899:0.011249:0.009827:0.009782:0.009903:0.014182:0.005020
pensated chronic heart failure often results in hospital :@0.519027:0.198132:0.927982:0.198132:0.927982:0.182349:0.519027:0.182349:0.010311:0.009827:0.009223:0.005866:0.010326:0.005125:0.009827:0.010357:0.006199:0.009782:0.009223:0.004551:0.009888:0.009223:0.003024:0.009782:0.006199:0.009223:0.009827:0.010326:0.004551:0.005125:0.006184:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.006199:0.009903:0.004747:0.005125:0.009827:0.009223:0.006184:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.006199:0.003024:0.009223:0.006199:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.004188
admission and has a bearing on prognosis.:@0.519027:0.212795:0.831144:0.212795:0.831144:0.197012:0.519027:0.197012:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.010326:0.009223:0.010357:0.004188:0.009223:0.010326:0.005866:0.004188:0.010326:0.004188:0.010311:0.009827:0.010326:0.004551:0.003024:0.009223:0.010175:0.004188:0.009903:0.009223:0.004188:0.010311:0.004551:0.009903:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188
The:@0.533314:0.227458:0.558805:0.227458:0.558805:0.211675:0.533314:0.211675:0.006441:0.009223:0.009827
 :@0.558805:0.227458:0.563038:0.227458:0.563038:0.210959:0.558805:0.210959:0.004233
New York Heart Association Functional Classifica:@0.563507:0.227458:0.918759:0.227458:0.918759:0.211675:0.563507:0.211675:0.011188:0.009827:0.012564:0.004657:0.008950:0.009903:0.004551:0.007590:0.004642:0.010326:0.009827:0.010326:0.004551:0.005125:0.004657:0.011188:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004657:0.007333:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.004657:0.012292:0.003024:0.010326:0.005866:0.005866:0.003024:0.003681:0.003681:0.009782:0.010326
-:@0.918774:0.227458:0.923794:0.227458:0.923794:0.211675:0.918774:0.211675:0.005020
tion  of cardiac failure is used to  differentiate  among :@0.519027:0.242120:0.927967:0.242120:0.927967:0.226338:0.519027:0.226338:0.005125:0.003024:0.009903:0.009223:0.004188:0.002963:0.009903:0.004747:0.007166:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.007166:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.007166:0.003024:0.005866:0.007166:0.009192:0.005866:0.009827:0.010357:0.007166:0.005125:0.009903:0.004188:0.002963:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.009827:0.009223:0.005125:0.003024:0.010326:0.005125:0.009827:0.004188:0.002963:0.010326:0.014182:0.009903:0.009223:0.010175:0.004188
various classes of cardiac failure, depending on symp-:@0.519027:0.256783:0.923779:0.256783:0.923779:0.241000:0.519027:0.241000:0.008376:0.010326:0.004551:0.003024:0.009903:0.009192:0.005866:0.005201:0.009782:0.003024:0.010326:0.005866:0.005866:0.009827:0.005866:0.005201:0.009903:0.004747:0.005186:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.005201:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.005186:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.003024:0.009223:0.010175:0.005186:0.009903:0.009223:0.005186:0.005866:0.008104:0.014182:0.010311:0.005020
toms. It also determines eventual therapy (see Table 1).:@0.519027:0.271446:0.922826:0.271446:0.922826:0.255663:0.519027:0.255663:0.005125:0.009903:0.014182:0.005866:0.004188:0.004188:0.003417:0.005125:0.004188:0.010326:0.003024:0.005866:0.009903:0.004188:0.010357:0.009827:0.005125:0.009827:0.004551:0.014182:0.003024:0.009223:0.009827:0.005866:0.004188:0.009827:0.008376:0.009827:0.009223:0.005125:0.009192:0.010326:0.003024:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.005579:0.005866:0.009827:0.009827:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.005579:0.004188
Table 1. Functional classification of cardiac failure:@0.519887:0.304645:0.884558:0.304645:0.884558:0.288147:0.519887:0.288147:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.007257:0.009071:0.009071:0.009676:0.004536:0.003629:0.009676:0.009071:0.009979:0.003629:0.004233:0.009676:0.003629:0.009979:0.006652:0.006652:0.003629:0.003931:0.003931:0.009676:0.009979:0.004536:0.003629:0.009676:0.009071:0.004233:0.009676:0.004233:0.004233:0.009676:0.009979:0.004838:0.009979:0.003629:0.009979:0.009676:0.004233:0.004233:0.009979:0.003629:0.003629:0.009071:0.004838:0.009676
Class I:@0.524927:0.323494:0.564908:0.323494:0.564908:0.309465:0.524927:0.309465:0.010926:0.002688:0.009179:0.005214:0.005214:0.003723:0.003037
No limitation of physical activity. Ordinary :@0.637009:0.323494:0.909770:0.323494:0.909770:0.309465:0.637009:0.309465:0.009945:0.008803:0.003723:0.002688:0.002688:0.012606:0.002688:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723:0.003723:0.011679:0.004045:0.009206:0.002688:0.008198:0.009179:0.004045:0.007203:0.003723
physical activity does not cause undue :@0.637009:0.336322:0.895377:0.336322:0.895377:0.322293:0.637009:0.322293:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723:0.009206:0.008803:0.008735:0.005214:0.003723:0.008198:0.008803:0.004556:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.008171:0.008198:0.009206:0.008171:0.008735:0.003723
breathlessness, fatigue, or palpitations.:@0.637009:0.349150:0.887958:0.349150:0.887958:0.335121:0.637009:0.335121:0.009165:0.004045:0.008735:0.009179:0.004556:0.008198:0.002688:0.008735:0.005214:0.005214:0.008198:0.008735:0.005214:0.005214:0.003723:0.003723:0.004220:0.009179:0.004556:0.002688:0.009045:0.008171:0.008735:0.003723:0.003723:0.008803:0.004045:0.003723:0.009165:0.009179:0.002688:0.009165:0.002688:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723
Class II:@0.524927:0.364544:0.567945:0.364544:0.567945:0.350515:0.524927:0.350515:0.010926:0.002688:0.009179:0.005214:0.005214:0.003723:0.003037:0.003037
slight limitation of physical activity. :@0.637009:0.364544:0.864924:0.364544:0.864924:0.350515:0.637009:0.350515:0.006693:0.002688:0.002688:0.009045:0.008198:0.004556:0.003723:0.002688:0.002688:0.012606:0.002688:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723:0.003723
Comfortable at rest, but ordinary physical :@0.637009:0.377373:0.911369:0.377373:0.911369:0.363344:0.637009:0.363344:0.010926:0.008803:0.012606:0.004220:0.008803:0.004045:0.004556:0.009179:0.009165:0.002688:0.008735:0.003723:0.009179:0.004556:0.003723:0.004045:0.008735:0.005214:0.004556:0.003723:0.003723:0.009165:0.008171:0.004556:0.003723:0.008803:0.004045:0.009206:0.002688:0.008198:0.009179:0.004045:0.007203:0.003723:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723
activity results in undue breathlessness, :@0.637009:0.390201:0.891439:0.390201:0.891439:0.376172:0.637009:0.376172:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723:0.004045:0.008735:0.005214:0.008171:0.002688:0.004556:0.005214:0.003723:0.002688:0.008198:0.003723:0.008171:0.008198:0.009206:0.008171:0.008735:0.003723:0.009165:0.004045:0.008735:0.009179:0.004556:0.008198:0.002688:0.008735:0.005214:0.005214:0.008198:0.008735:0.005214:0.005214:0.003723:0.003723
fatigue or palpitations.:@0.637009:0.403029:0.783697:0.403029:0.783697:0.389000:0.637009:0.389000:0.004220:0.009179:0.004556:0.002688:0.009045:0.008171:0.008735:0.003723:0.008803:0.004045:0.003723:0.009165:0.009179:0.002688:0.009165:0.002688:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723
Class III:@0.524927:0.418423:0.570983:0.418423:0.570983:0.404394:0.524927:0.404394:0.010926:0.002688:0.009179:0.005214:0.005214:0.003723:0.003037:0.003037:0.003037
Marked limitation of physical activity. :@0.637009:0.418423:0.881319:0.418423:0.881319:0.404394:0.637009:0.404394:0.012351:0.009179:0.004045:0.006746:0.008735:0.009206:0.003723:0.002688:0.002688:0.012606:0.002688:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723:0.003723
Comfortable at rest, but less than :@0.637009:0.431251:0.856954:0.431251:0.856954:0.417222:0.637009:0.417222:0.010926:0.008803:0.012606:0.004220:0.008803:0.004045:0.004556:0.009179:0.009165:0.002688:0.008735:0.003723:0.009179:0.004556:0.003723:0.004045:0.008735:0.005214:0.004556:0.003723:0.003723:0.009165:0.008171:0.004556:0.003723:0.002688:0.008735:0.005214:0.005214:0.003723:0.004556:0.008198:0.009179:0.008198:0.003723
ordinary physical activity results in undue :@0.637009:0.444080:0.904744:0.444080:0.904744:0.430051:0.637009:0.430051:0.008803:0.004045:0.009206:0.002688:0.008198:0.009179:0.004045:0.007203:0.003723:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723:0.004045:0.008735:0.005214:0.008171:0.002688:0.004556:0.005214:0.003723:0.002688:0.008198:0.003723:0.008171:0.008198:0.009206:0.008171:0.008735:0.003723
breathlessness, fatigue or palpitations.:@0.637009:0.456908:0.884236:0.456908:0.884236:0.442879:0.637009:0.442879:0.009165:0.004045:0.008735:0.009179:0.004556:0.008198:0.002688:0.008735:0.005214:0.005214:0.008198:0.008735:0.005214:0.005214:0.003723:0.003723:0.004220:0.009179:0.004556:0.002688:0.009045:0.008171:0.008735:0.003723:0.008803:0.004045:0.003723:0.009165:0.009179:0.002688:0.009165:0.002688:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723
Class IV:@0.524927:0.472302:0.574342:0.472302:0.574342:0.458273:0.524927:0.458273:0.010926:0.002688:0.009179:0.005214:0.005214:0.003723:0.003037:0.009434
Unable to carry on any physical activity :@0.637009:0.472302:0.897984:0.472302:0.897984:0.458273:0.637009:0.458273:0.008803:0.008198:0.009179:0.009165:0.002688:0.008735:0.003723:0.004556:0.008803:0.003723:0.008695:0.009179:0.004045:0.004045:0.007203:0.003723:0.008803:0.008198:0.003723:0.009179:0.008198:0.007203:0.003723:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723
without discomfort. symptoms at rest :@0.637009:0.485130:0.879451:0.485130:0.879451:0.471101:0.637009:0.471101:0.011168:0.002688:0.004556:0.008198:0.008803:0.008171:0.004556:0.003723:0.009206:0.002688:0.005214:0.008695:0.008803:0.012606:0.004220:0.008803:0.004045:0.004556:0.003723:0.003723:0.006693:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.009179:0.004556:0.003723:0.004045:0.008735:0.005214:0.004556:0.003723
can be present. If any physical activity is :@0.637009:0.497958:0.902916:0.497958:0.902916:0.483929:0.637009:0.483929:0.008695:0.009179:0.008198:0.003723:0.009165:0.008735:0.003723:0.009165:0.004045:0.008735:0.005214:0.008735:0.008198:0.004556:0.003723:0.003723:0.003037:0.004220:0.003723:0.009179:0.008198:0.007203:0.003723:0.009165:0.008198:0.007203:0.005214:0.002688:0.008695:0.009179:0.002688:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.002688:0.004556:0.007203:0.003723:0.002688:0.005214:0.003723
undertaken, discomfort is increased.:@0.637009:0.510787:0.872826:0.510787:0.872826:0.496758:0.637009:0.496758:0.008171:0.008198:0.009206:0.008735:0.004045:0.004556:0.009179:0.006746:0.008735:0.008198:0.003723:0.003723:0.009206:0.002688:0.005214:0.008695:0.008803:0.012606:0.004220:0.008803:0.004045:0.004556:0.003723:0.002688:0.005214:0.003723:0.002688:0.008198:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.009206:0.003723
source: New York Heart Association:@0.526607:0.526107:0.728584:0.526107:0.728584:0.513832:0.526607:0.513832:0.005856:0.007702:0.007150:0.003540:0.007608:0.007644:0.003257:0.003257:0.008702:0.007644:0.009772:0.003257:0.006961:0.007702:0.003540:0.005903:0.003257:0.008032:0.007644:0.008032:0.003540:0.003986:0.003257:0.008702:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173
treAtment ObJeCtiVes :@0.519047:0.568641:0.730815:0.568641:0.730815:0.548477:0.519047:0.548477:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761:0.005174:0.015522:0.010718:0.008870:0.009609:0.014413:0.007761:0.005174:0.012935:0.009609:0.009609:0.005174
The objectives of correctly managing heart failure are :@0.519047:0.585080:0.927987:0.585080:0.927987:0.569297:0.519047:0.569297:0.006441:0.009223:0.009827:0.005670:0.009903:0.010311:0.003069:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.005866:0.005685:0.009903:0.004747:0.005685:0.009782:0.009903:0.004551:0.004551:0.009827:0.009782:0.005125:0.003024:0.008104:0.005670:0.014182:0.010326:0.009223:0.010326:0.010175:0.003024:0.009223:0.010175:0.005685:0.009223:0.009827:0.010326:0.004551:0.005125:0.005670:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005685:0.010326:0.004551:0.009827:0.004188
to improve the clinical status, functional capacity, qual-:@0.519047:0.599742:0.923799:0.599742:0.923799:0.583960:0.519047:0.583960:0.005125:0.009903:0.003719:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.003719:0.005125:0.009223:0.009827:0.003719:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003734:0.005866:0.005125:0.010326:0.005125:0.009192:0.005866:0.004188:0.003719:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003719:0.009782:0.010326:0.010311:0.010326:0.009782:0.003024:0.005125:0.008104:0.004188:0.003734:0.010311:0.009192:0.010326:0.003024:0.005020
ity of life and to prevent hospital admissions. Treatment :@0.519047:0.614405:0.928002:0.614405:0.928002:0.598622:0.519047:0.598622:0.003024:0.005125:0.008104:0.004732:0.009903:0.004747:0.004717:0.003024:0.003024:0.004747:0.009827:0.004732:0.010326:0.009223:0.010357:0.004732:0.005125:0.009903:0.004717:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.004717:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.004732:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.005866:0.004188:0.004732:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188
is targeted  at modifying maladaptive  neurohumoral :@0.519047:0.629068:0.928002:0.629068:0.928002:0.613285:0.519047:0.613285:0.003024:0.005866:0.008814:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.009827:0.010357:0.004188:0.004611:0.010326:0.005125:0.008814:0.014182:0.009903:0.010357:0.003024:0.004747:0.008104:0.003024:0.009223:0.010175:0.008814:0.014182:0.010326:0.003024:0.010326:0.010357:0.010326:0.010311:0.005125:0.003024:0.008376:0.009827:0.004188:0.004642:0.009223:0.009827:0.009192:0.004551:0.009903:0.009223:0.009192:0.014182:0.009903:0.004551:0.010326:0.003024:0.004188
responses, thereby improving symptoms and survival. It :@0.519047:0.643731:0.927972:0.643731:0.927972:0.627948:0.519047:0.627948:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.005866:0.004188:0.005110:0.005125:0.009223:0.009827:0.004536:0.009827:0.010311:0.008104:0.005110:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.003024:0.009223:0.010175:0.005110:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.005110:0.010326:0.009223:0.010357:0.005110:0.005866:0.009192:0.004551:0.008376:0.003024:0.008376:0.010326:0.003024:0.004188:0.005125:0.003417:0.005125:0.004188
is of utmost importance to treat patients appropriately :@0.519047:0.658393:0.927987:0.658393:0.927987:0.642611:0.519047:0.642611:0.003024:0.005866:0.005307:0.009903:0.004747:0.005292:0.009192:0.005125:0.014182:0.009903:0.005866:0.005125:0.005292:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.009782:0.009827:0.005292:0.005125:0.009903:0.005292:0.005125:0.004551:0.009827:0.010326:0.005125:0.005292:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005292:0.010326:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.003024:0.008104:0.004188
and timeously, as recurrent hospital admissions impact :@0.519047:0.673056:0.927987:0.673056:0.927987:0.657273:0.519047:0.657273:0.010326:0.009223:0.010357:0.005397:0.005125:0.003024:0.014182:0.009827:0.009903:0.009192:0.005866:0.003024:0.008104:0.004188:0.005397:0.010326:0.005866:0.005397:0.004551:0.009827:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.005382:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.005413:0.010326:0.010357:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.005866:0.005413:0.003024:0.014182:0.010311:0.010326:0.009782:0.005125:0.004188
on morbidity, mortality and ultimately prognosis. :@0.519047:0.687719:0.873301:0.687719:0.873301:0.671936:0.519047:0.671936:0.009903:0.009223:0.004188:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.008104:0.004188:0.004188:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.010326:0.009223:0.010357:0.004188:0.009192:0.003024:0.005125:0.003024:0.014182:0.010326:0.005125:0.009827:0.003024:0.008104:0.004188:0.010311:0.004551:0.009903:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188
PHArmACOlOGiCAl treAtment Of HeArt :@0.519047:0.721111:0.903776:0.721111:0.903776:0.700946:0.519047:0.700946:0.010348:0.012566:0.013674:0.010718:0.016631:0.013674:0.014413:0.015522:0.008131:0.015522:0.015522:0.005174:0.014413:0.013674:0.008131:0.005174:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761:0.005174:0.015522:0.008870:0.005174:0.012566:0.009609:0.013674:0.010718:0.007761:0.005174
fAilure WitH reDuCeD eJeCtiOn frACtiOn :@0.519047:0.738341:0.911538:0.738341:0.911538:0.718176:0.519047:0.718176:0.008870:0.013674:0.005174:0.008131:0.011826:0.010718:0.009609:0.005174:0.016631:0.005174:0.007761:0.012566:0.005174:0.010718:0.009609:0.012935:0.011826:0.014413:0.009609:0.012935:0.005174:0.009609:0.008870:0.009609:0.014413:0.007761:0.005174:0.015522:0.013674:0.005174:0.008870:0.010718:0.013674:0.014413:0.007761:0.005174:0.015522:0.013674:0.005174
Angiotensin-converting  enzyme  inhibitors (ACEIs), an-:@0.519047:0.754776:0.923814:0.754776:0.923814:0.738993:0.519047:0.738993:0.011188:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.005020:0.009782:0.009903:0.009223:0.008376:0.009827:0.004551:0.005125:0.003024:0.009223:0.010175:0.004188:0.004067:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.004188:0.004082:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.008285:0.005579:0.011188:0.012292:0.008104:0.003417:0.005866:0.005579:0.004188:0.008285:0.010326:0.009223:0.005020
giotensin receptor  blockers (ARBs), mineralocorticoid :@0.519047:0.769439:0.928002:0.769439:0.928002:0.753656:0.519047:0.753656:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.008724:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.004188:0.004521:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.008724:0.005579:0.011188:0.009177:0.008678:0.005866:0.005579:0.004188:0.008724:0.014182:0.003024:0.009223:0.009827:0.004551:0.010326:0.003024:0.009903:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.003024:0.010357:0.004188
antagonists (MRAs) and beta-blockers (BBs)  form  the :@0.519047:0.784101:0.928002:0.784101:0.928002:0.768319:0.519047:0.768319:0.010326:0.009223:0.005125:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.005866:0.007665:0.005579:0.013894:0.009177:0.011188:0.005866:0.005579:0.007665:0.010326:0.009223:0.010357:0.007665:0.010311:0.009827:0.005125:0.010326:0.005020:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.007665:0.005579:0.008678:0.008678:0.005866:0.005579:0.004188:0.003492:0.004747:0.009903:0.004551:0.014182:0.004188:0.003462:0.005125:0.009223:0.009827:0.004188
cornerstone  of cardiac-failure treatment  for  patients :@0.519047:0.798764:0.927987:0.798764:0.927987:0.782981:0.519047:0.782981:0.009782:0.009903:0.004551:0.009223:0.009827:0.004551:0.005866:0.005125:0.009903:0.009223:0.009827:0.004188:0.004430:0.009903:0.004747:0.008633:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.005020:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.008633:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.004430:0.004747:0.009903:0.004551:0.004188:0.004430:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
with reduced ejection fraction. :@0.519047:0.813427:0.750278:0.813427:0.750278:0.797644:0.519047:0.797644:0.012564:0.003024:0.005125:0.009223:0.004188:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.004188:0.009827:0.003069:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
Angiotensin  receptor  blocker-neprilysin  inhibitors :@0.533335:0.828089:0.927987:0.828089:0.927987:0.812307:0.533335:0.812307:0.011188:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.004188:0.012927:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.004188:0.012912:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005020:0.009223:0.009827:0.010311:0.004551:0.003024:0.003024:0.008104:0.005866:0.003024:0.009223:0.004188:0.012927:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188
(ARNIs),  combine  the  effects  of  valsartan and  sacu-:@0.519047:0.842752:0.923784:0.842752:0.923784:0.826970:0.519047:0.826970:0.005579:0.011188:0.009177:0.011188:0.003417:0.005866:0.005579:0.004188:0.004188:0.003855:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.009827:0.004188:0.003855:0.005125:0.009223:0.009827:0.004188:0.003855:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.003855:0.009903:0.004747:0.004188:0.003855:0.008376:0.010326:0.003024:0.005866:0.010326:0.004551:0.005125:0.010326:0.009223:0.008058:0.010326:0.009223:0.010357:0.004188:0.003855:0.005866:0.010326:0.009782:0.009192:0.005020
bitril in boosting plasma levels of BNp, and have been :@0.519047:0.857415:0.927987:0.857415:0.927987:0.841632:0.519047:0.841632:0.010311:0.003024:0.005125:0.004551:0.003024:0.003024:0.005715:0.003024:0.009223:0.005715:0.010311:0.009903:0.009903:0.005866:0.005125:0.003024:0.009223:0.010160:0.005715:0.010311:0.003024:0.010326:0.005866:0.014182:0.010326:0.005730:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.005715:0.009903:0.004747:0.005715:0.008678:0.011188:0.008950:0.004188:0.005715:0.010326:0.009223:0.010357:0.005715:0.009223:0.010326:0.008376:0.009827:0.005715:0.010311:0.009827:0.009827:0.009223:0.004188
shown to be superior to ACE inhibitors, i.e. enalapril, by :@0.519047:0.872078:0.928017:0.872078:0.928017:0.856295:0.519047:0.856295:0.005866:0.009223:0.009903:0.012564:0.009223:0.004899:0.005125:0.009903:0.004899:0.010311:0.009827:0.004899:0.005866:0.009192:0.010311:0.009827:0.004551:0.003024:0.009903:0.004551:0.004883:0.005125:0.009903:0.004899:0.011188:0.012292:0.008104:0.004899:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188:0.004899:0.003024:0.004188:0.009827:0.004188:0.004899:0.009827:0.009223:0.010326:0.003024:0.010326:0.010311:0.004551:0.003024:0.003024:0.004188:0.004899:0.010311:0.008104:0.004188
reducing hospitalisation for heart failure (21% RRR), and :@0.519047:0.886740:0.928002:0.886740:0.928002:0.870958:0.519047:0.870958:0.004551:0.009827:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.004445:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004460:0.004747:0.009903:0.004551:0.004445:0.009223:0.009827:0.010326:0.004551:0.005125:0.004445:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004445:0.005579:0.008376:0.008376:0.011717:0.004460:0.009177:0.009177:0.009177:0.005579:0.004188:0.004445:0.010326:0.009223:0.010357:0.004188
significantly reducing cardiovascular death (20 % RRR) :@0.519047:0.901403:0.927987:0.901403:0.927987:0.885620:0.519047:0.885620:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.003024:0.008104:0.005503:0.004551:0.009827:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.005488:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005503:0.010357:0.009827:0.010326:0.005125:0.009223:0.005488:0.005579:0.008376:0.008376:0.005488:0.011717:0.005488:0.009177:0.009177:0.009177:0.005579:0.004188
and all-cause mortality (16% RRR). This drug has been :@0.519032:0.916066:0.927987:0.916066:0.927987:0.900283:0.519032:0.900283:0.010326:0.009223:0.010357:0.006290:0.010326:0.003024:0.003024:0.005020:0.009782:0.010326:0.009192:0.005866:0.009827:0.006305:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.006290:0.005579:0.008376:0.008376:0.011717:0.006290:0.009177:0.009177:0.009177:0.005579:0.004188:0.006290:0.006441:0.009223:0.003024:0.005866:0.006290:0.010357:0.004551:0.009192:0.010175:0.006290:0.009223:0.010326:0.005866:0.006290:0.010311:0.009827:0.009827:0.009223:0.004188
an  exciting  development  in  the  field  of  heart-failure :@0.519032:0.930728:0.927957:0.930728:0.927957:0.914946:0.519032:0.914946:0.010326:0.009223:0.004188:0.004007:0.009827:0.007257:0.009782:0.003024:0.005125:0.003024:0.009223:0.010175:0.004188:0.004007:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.014182:0.009827:0.009223:0.005125:0.004188:0.004007:0.003024:0.009223:0.004188:0.004007:0.005125:0.009223:0.009827:0.004188:0.004007:0.003681:0.003681:0.009827:0.003024:0.010357:0.004188:0.004007:0.009903:0.004747:0.004188:0.004007:0.009223:0.009827:0.010326:0.004551:0.005125:0.005020:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188
 :@0.923799:0.930728:0.927987:0.930728:0.927987:0.914946:0.923799:0.914946:0.004188
management.:@0.519032:0.945391:0.625637:0.945391:0.625637:0.929609:0.519032:0.929609:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188